Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11015201 Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Patent 11015201 was granted and assigned to Alnylam Pharmaceuticals on May, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+324 characters)
Article

Patent abstract

The present invention relates to RNAi agents, e.g., double stranded RNA (dsRNA) agents, targeting the AGT gene. The invention also relates to methods of using such RNAi agents to inhibit expression of an AGT gene and to methods of preventing and treating an AGT-associated disorder, e.g., high blood pressure.

Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834661 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
0
Edits on 18 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 18 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1101520100
Edits on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Edits on 1 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Edits on 24 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 24 Mar, 2023
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 6 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=11015201
Edits on 12 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 12 Feb, 2022
Edits made to:
Infobox (+11 properties)
‌

 US Patent 11015201 Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Infobox
Is a
Patent
Patent
Patent applicant
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Current assignee
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11015201
Date of patent
May 25, 2021
Patent application number
17093816
Date Filed
November 10, 2020
Patent citations
‌
US Patent 10238749 Angiotensinogen (AGT) iRNA compositions and methods of use thereof
‌
US Patent 10709728 Polynucleotide agents targeting angiotensinogen (AGT) and methods of use thereof
Patent primary examiner
‌
Ekaterina Poliakova-Georgantas

Find more entities like US Patent 11015201 Angiotensinogen (AGT) iRNA compositions and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo